In this study, to overcome the tumor-induced immunotolerance, a simple and safe strategy with IFN-α and/or IL-2 was used to selectively and efficiently downregulate Treg and upregulate NK cells in malignant patients. This evidence concerns the gene IL2 and neoplasm.